In agreement to this, our analysis revealed that while MAGED1, which is co-expressed with MAGED4, was associated with poor prognosis in glioma, it did not emerge as an independent prognostic factor in multivariate analysis. The gene discussed is MAGED4; the disease is central nervous system cancer.